Search Results for keywords:"National Institute of Allergy and Infectious Diseases"

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting for the Special Emphasis Panel focused on promoting research in Treponema Pallidum pathogenesis. This meeting, scheduled for April 8, 2025, will take place from 10:00 a.m. to 6:00 p.m. via a video-assisted format. The review and evaluation of grant applications will occur, and sensitive information will remain confidential due to privacy and trade secret concerns. Queries can be directed to Dr. Mairi Noverr, the designated contact at NIAID.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting scheduled for March 15-17, 2021. The meeting will be held virtually to review and evaluate grant applications related to microbiology and infectious diseases. It is closed to the public to protect confidential information and personal privacy. Interested parties can contact Ellen S. Buczko, Ph.D., for more information about the meeting.

The National Institute of Allergy and Infectious Diseases has announced that a meeting will be held on February 5-6, 2025. The meeting will be closed to the public under federal law due to discussions of confidential topics and personal information. The focus of the meeting will be to review and evaluate grant applications related to microbiology, infectious diseases, and AIDS. This video-assisted meeting will take place at the National Institutes of Health in Rockville, Maryland.

The National Institute of Allergy and Infectious Diseases announced closed meetings scheduled for February 5, 2021. These meetings are not open to the public to protect confidential information, such as trade secrets and personal privacy. The committees will review and evaluate contract proposals related to improving technologies for large-scale high-titer phage preparations. Frank S. De Silva, Ph.D., is the contact person for these meetings.

The National Institute of Allergy and Infectious Diseases is holding a closed virtual meeting on February 8, 2021, to review and evaluate grant applications. The meeting is closed to the public to protect confidential trade secrets, commercial property, and personal information. This session focuses on the Nonhuman Primate Reagent Resource, with no clinical trials allowed. Those interested in further details can contact Dr. Tara Capece, the Scientific Review Officer.

The National Institute of Allergy and Infectious Diseases (NIAID) is holding a closed meeting on April 24, 2025, to review grant applications related to inducing HIV immunity in early life. This meeting will take place at the NIAID's facility in Rockville, Maryland, and will be conducted via video assistance. The discussions will cover confidential trade secrets and personal information, which is why the meeting is not open to the public. The meeting is organized under the guidelines of the Federal Advisory Committee Act.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on February 12, 2021, to review and evaluate grant applications. The meeting is not open to the public because it may reveal confidential trade secrets, commercial property, or personal information. The discussion will include applications for trial planning and clinical trial implementation grants. The notice was issued less than 15 days before the meeting because of time constraints related to the review and funding process.

The National Institute of Allergy and Infectious Diseases announced a closed meeting of its Special Emphasis Panel. This meeting, set for February 26, 2021, will focus on reviewing and evaluating grant applications without public access, as it might involve sensitive personal information and confidential data, like trade secrets and potential patents. The meeting will occur virtually, ensuring the confidentiality of the discussions. For further details, interested parties can contact Dr. Ellen S. Buczko at the National Institutes of Health.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on March 19, 2021, from 11:30 a.m. to 2:00 p.m. The meeting is set to evaluate contract proposals and will be held virtually at the National Institutes of Health. It will remain closed to the public to protect confidential information, including trade secrets and personal data. Kelly L. Hudspeth, Ph.D., is the contact person for more details on the meeting.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 17, 2025, to review contract proposals related to NeuroHIV research. This meeting, conducted through a video-assisted format, will not be open to the public because it will involve discussions of confidential trade secrets and personal information. Dr. Mohammed S. Aiyegbo is the contact person for this meeting. The meeting will be held at the National Institutes of Health facility in Rockville, MD.